In FluoroDeoxyGlucose, a radiotracer (radiopharmaceutical) is injected into the bloodstream. __ uses glucose at a much higher rate than normal cells

Study for the Image Modalities Test. Learn with flashcards and multiple choice questions, each comes with hints and explanations. Get ready for your credentialing exam in the field of medical imaging!

Multiple Choice

In FluoroDeoxyGlucose, a radiotracer (radiopharmaceutical) is injected into the bloodstream. __ uses glucose at a much higher rate than normal cells

Explanation:
FDG PET imaging relies on how much glucose cells are using. Cancer cells typically consume much more glucose than normal cells because they rely heavily on glycolysis, even when oxygen is available. This elevated glucose use means they take up more FluoroDeoxyGlucose and trap it inside, since FDG is phosphorylated but not further metabolized, leading to strong signals on the scan. Normal cells use glucose at baseline levels, so their FDG uptake is comparatively lower. Infected tissue can show increased uptake due to inflammation, but not to the same sustained, high level as cancer. Bones don’t inherently have the high, abnormal glucose metabolism characteristic of malignant tissue. So the bright, high uptake of FDG best identifies cancerous tissue.

FDG PET imaging relies on how much glucose cells are using. Cancer cells typically consume much more glucose than normal cells because they rely heavily on glycolysis, even when oxygen is available. This elevated glucose use means they take up more FluoroDeoxyGlucose and trap it inside, since FDG is phosphorylated but not further metabolized, leading to strong signals on the scan. Normal cells use glucose at baseline levels, so their FDG uptake is comparatively lower. Infected tissue can show increased uptake due to inflammation, but not to the same sustained, high level as cancer. Bones don’t inherently have the high, abnormal glucose metabolism characteristic of malignant tissue. So the bright, high uptake of FDG best identifies cancerous tissue.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy